419 related articles for article (PubMed ID: 34671250)
1. The Unifying Hypothesis of Alzheimer's Disease: Heparan Sulfate Proteoglycans/Glycosaminoglycans Are Key as First Hypothesized Over 30 Years Ago.
Snow AD; Cummings JA; Lake T
Front Aging Neurosci; 2021; 13():710683. PubMed ID: 34671250
[TBL] [Abstract][Full Text] [Related]
2. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain.
Snow AD; Sekiguchi RT; Nochlin D; Kalaria RN; Kimata K
Am J Pathol; 1994 Feb; 144(2):337-47. PubMed ID: 8311117
[TBL] [Abstract][Full Text] [Related]
3. The sulfate moieties of glycosaminoglycans are critical for the enhancement of beta-amyloid protein fibril formation.
Castillo GM; Lukito W; Wight TN; Snow AD
J Neurochem; 1999 Apr; 72(4):1681-7. PubMed ID: 10098877
[TBL] [Abstract][Full Text] [Related]
4. Identification in immunolocalization of a new class of proteoglycan (keratan sulfate) to the neuritic plaques of Alzheimer's disease.
Snow AD; Nochlin D; Sekiguichi R; Carlson SS
Exp Neurol; 1996 Apr; 138(2):305-17. PubMed ID: 8620929
[TBL] [Abstract][Full Text] [Related]
5. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease.
Snow AD; Mar H; Nochlin D; Kimata K; Kato M; Suzuki S; Hassell J; Wight TN
Am J Pathol; 1988 Dec; 133(3):456-63. PubMed ID: 2974240
[TBL] [Abstract][Full Text] [Related]
6. Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie.
Snow AD; Wight TN; Nochlin D; Koike Y; Kimata K; DeArmond SJ; Prusiner SB
Lab Invest; 1990 Nov; 63(5):601-11. PubMed ID: 1977959
[TBL] [Abstract][Full Text] [Related]
7. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease and heparan sulfate proteoglycan.
Fukuchi K; Hart M; Li L
Front Biosci; 1998 Mar; 3():d327-37. PubMed ID: 9490646
[TBL] [Abstract][Full Text] [Related]
9. Towards understanding the roles of heparan sulfate proteoglycans in Alzheimer's disease.
Zhang GL; Zhang X; Wang XM; Li JP
Biomed Res Int; 2014; 2014():516028. PubMed ID: 25157361
[TBL] [Abstract][Full Text] [Related]
10. Role of proteoglycans and glycosaminoglycans in the pathogenesis of Alzheimer's disease and related disorders: amyloidogenesis and therapeutic strategies--a review.
Ariga T; Miyatake T; Yu RK
J Neurosci Res; 2010 Aug; 88(11):2303-15. PubMed ID: 20623617
[TBL] [Abstract][Full Text] [Related]
11. Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains.
van Horssen J; Otte-Höller I; David G; Maat-Schieman ML; van den Heuvel LP; Wesseling P; de Waal RM; Verbeek MM
Acta Neuropathol; 2001 Dec; 102(6):604-14. PubMed ID: 11761721
[TBL] [Abstract][Full Text] [Related]
12. Abeta(1-40) prevents heparanase-catalyzed degradation of heparan sulfate glycosaminoglycans and proteoglycans in vitro. A role for heparan sulfate proteoglycan turnover in Alzheimer's disease.
Bame KJ; Danda J; Hassall A; Tumova S
J Biol Chem; 1997 Jul; 272(27):17005-11. PubMed ID: 9202014
[TBL] [Abstract][Full Text] [Related]
13. Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid-β clearance and aggregation in Alzheimer's disease.
Liu CC; Zhao N; Yamaguchi Y; Cirrito JR; Kanekiyo T; Holtzman DM; Bu G
Sci Transl Med; 2016 Mar; 8(332):332ra44. PubMed ID: 27030596
[TBL] [Abstract][Full Text] [Related]
14. Aluminum modifies the properties of Alzheimer's disease PHF tau proteins in vivo and in vitro.
Shin RW; Lee VM; Trojanowski JQ
J Neurosci; 1994 Nov; 14(11 Pt 2):7221-33. PubMed ID: 7525898
[TBL] [Abstract][Full Text] [Related]
15. Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tau
Stopschinski BE; Holmes BB; Miller GM; Manon VA; Vaquer-Alicea J; Prueitt WL; Hsieh-Wilson LC; Diamond MI
J Biol Chem; 2018 Jul; 293(27):10826-10840. PubMed ID: 29752409
[TBL] [Abstract][Full Text] [Related]
16. In vitro comparison of major memory-support dietary supplements for their effectiveness in reduction/inhibition of beta-amyloid protein fibrils and tau protein tangles: key primary targets for memory loss.
Snow AD; Cummings JA; Tanzi RE; Lake T
Sci Rep; 2021 Feb; 11(1):3001. PubMed ID: 33589649
[TBL] [Abstract][Full Text] [Related]
17. Heparan sulfate accumulation with Abeta deposits in Alzheimer's disease and Tg2576 mice is contributed by glial cells.
O'Callaghan P; Sandwall E; Li JP; Yu H; Ravid R; Guan ZZ; van Kuppevelt TH; Nilsson LN; Ingelsson M; Hyman BT; Kalimo H; Lindahl U; Lannfelt L; Zhang X
Brain Pathol; 2008 Oct; 18(4):548-61. PubMed ID: 18422760
[TBL] [Abstract][Full Text] [Related]
18. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
19. Heparan sulfate proteoglycan in Alzheimer's disease: aberrant expression and functions in molecular pathways related to amyloid-β metabolism.
Ozsan McMillan I; Li JP; Wang L
Am J Physiol Cell Physiol; 2023 Apr; 324(4):C893-C909. PubMed ID: 36878848
[TBL] [Abstract][Full Text] [Related]
20. Sulfation of heparan sulfate associated with amyloid-beta plaques in patients with Alzheimer's disease.
Bruinsma IB; te Riet L; Gevers T; ten Dam GB; van Kuppevelt TH; David G; Küsters B; de Waal RM; Verbeek MM
Acta Neuropathol; 2010 Feb; 119(2):211-20. PubMed ID: 19636575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
